Peter W. T. Pisters - Concepedia

Author

Peter W. T. Pisters

The University of Texas MD Anderson Cancer Center

Also Known As

Jeffrey E Lee, Jeffrey E. Lee, Jeffrey Peters, M Brennan, P Mansfield, P Pisters, P W Pisters, P W T Pisters, P. Pisters, P. W. Pisters

385

Publications

39.9K

Citations

108

H-Index

150

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Society of Surgical Oncology Cancer Support Community

About

Peter W. T. Pisters is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, surgical oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	64	109	13.9K
2	Health Sciences	16	17	1.6K
3	Engineering	2	2	60
4	Arts	1	1	24
5	Education	1	1	32

Peter W. T. Pisters

209

Publications

34.4K

Citations

101

H-Index

Page 1

	Year	Citations
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, The Lancet Surgical OncologyGastrointestinal OncologyMedicineGastroenterologyAdjuvant Imatinib Mesylate	2009	1.3K
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors George D. Demetri, Margaret von Mehren, Cristina R. Antonescu, Journal of the National Comprehensive Cancer Network Surgical OncologyImmunologyGastroenterologyPathologySurgery	2010	1.2K
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. Peter W. T. Pisters, Denis H. Y. Leung, James M. Woodruff, Journal of Clinical Oncology	1996	1.2K
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes James W. Fleshman, Megan E. Branda, Daniel J. Sargent, JAMA	2015	1.1K
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. Peter W. T. Pisters, L.B. Harrison, Denis H. Y. Leung, Journal of Clinical Oncology	1996	997
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans, Journal of the American College of Surgeons	2008	813
Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head Douglas B. Evans, Gauri R. Varadhachary, Christopher H. Crane, Journal of Clinical Oncology	2008	726
Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy Gunar K. Zagars, Matthew T. Ballo, Peter W. T. Pisters, Cancer	2003	666
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines George D. Demetri, Robert S. Benjamin, Charles D. Blanke, Journal of the National Comprehensive Cancer Network	2007	635
Soft tissue sarcomas of adults: state of the translational science. Ernest C. Borden, Laurence H. Baker, Robert S. Bell, PubMed Single Gene FamilyImatinib MesylateGastrointestinal OncologyMedicineTranslational Science	2003	616

Page 1